{"id":"NCT01383486","sponsor":"Bayer","briefTitle":"Self Selection Trial of Naproxen Sodium","officialTitle":"A Pilot Self Selection Trial of an Extended-Release Over-the-Counter Analgesic","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07","primaryCompletion":"2011-08","completion":"2011-08","firstPosted":"2011-06-28","resultsPosted":"2012-11-29","lastUpdate":"2015-10-15"},"enrollment":253,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":null},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Naproxen sodium ER (BAYH6689)","otherNames":[]},{"type":"DRUG","name":"Advil","otherNames":[]}],"arms":[{"label":"Naproxen Sodium ER (BAYH6689) or Advil IR","type":"EXPERIMENTAL"}],"summary":"A pilot trial to demonstrate that consumers can appropriately select Aleve 24 Hour for their own use based on expected duration of pain greater than 12 hours.","primaryOutcome":{"measure":"The Percentage of Participants Who Selected Naproxen Sodium ER and Expected Their Pain to Last More Than 12 Hours","timeFrame":"up to 14 days","effectByArm":[{"arm":"Naproxen Sodium ER (BAY H6689) or Advil IR","deltaMin":72,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.clinicaltrialsregister.eu/"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":237},"commonTop":["Back pain","Nephrolithiasis","Myalgia","Toothache","Headache"]}}